reference/9805050

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9805050

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	76
issn	0003-9926
issueIdentifier	14
pageRange	1568-76
publicationName	Archives of Internal Medicine
startingPage	1568
bibliographicCitation	Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter Research Group. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med. 2002 Jul 22;162(14):1568–76. doi: 10.1001/archinte.162.14.1568. PMID: 12123399.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d04eb4f77819f0548eb7f3581e48fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f805157e452fe641a95c9106b4b94354 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9c05356314701a9bbb09a5c8db3b105 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d5fd95bdf1a59c103b1d83ff69ec6a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fd0befd0f4112b88d87dcdf83a98056 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8fe205ff935d9f79e7459e7da48d353 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_163c89d90bea455b16c3dd3caefb2b3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5771afe9dd2afaa94eaf7788c330344 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d0fea84e0a73bce4bdf5a0e71d6d0cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b9fe102f7d277a79cf857fda04205fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9343984d1227662be742e5bffc1106a6
date	2002-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12123399 https://doi.org/10.1001/archinte.162.14.1568
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/767 https://portal.issn.org/resource/ISSN/0003-9926
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 DiabetesResults of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial
discusses	http://id.nlm.nih.gov/mesh/M0012591 http://id.nlm.nih.gov/mesh/M0021969 http://id.nlm.nih.gov/mesh/M0014807 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0003122 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0001459 http://id.nlm.nih.gov/mesh/M0012587
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000150 http://id.nlm.nih.gov/mesh/D000960Q000009 http://id.nlm.nih.gov/mesh/D006949Q000188 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D009525Q000008 http://id.nlm.nih.gov/mesh/D000960Q000008 http://id.nlm.nih.gov/mesh/D009525Q000009 http://id.nlm.nih.gov/mesh/D006949Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000097 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008076Q000097 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D008078Q000097 http://id.nlm.nih.gov/mesh/D008078Q000187 http://id.nlm.nih.gov/mesh/D023381 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014280Q000097 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001786Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001786Q000032 http://id.nlm.nih.gov/mesh/D008076Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019161Q000627 http://id.nlm.nih.gov/mesh/D002097Q000187 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015992 http://id.nlm.nih.gov/mesh/D006949Q000097 http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8544 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_58abb759e5602eec30e9e8ac773f9bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10895 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787884 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128974210

Total number of triples: 85.